FOR IMMEDIATE RELEASE

Compass Genomics, Inc.
6217 Mid Rivers Mall Drive, Suite 300
Saint Charles, MO  63304

CONTACT
Richard Lesh, President
636-219-6927
richard.lesh@compassgenomics.com


St. Louis University Signs Letter of Intent


St. Louis, MO - March 3, 2003 - Today St. Louis University signed a letter of intent to evaluate and potentially purchase the the LifePlexus system being developed by Compass Genomics.

"We are excited about the potential benefit of that system [LifePlexus] to Saint Louis University's technology commercialization efforts," states Joseph Zahner, Ph.D., Director of St. Louis University's Technology Transfer Office.  "We believe this product has great potential to improve our productivity (and thus lower the cost of technology commercialization) and to provide the security necessary to protect our intellectual property."

###